Axon snares Sanofi-Aventis diabetes chief

Axon Communications has recruited Sanofi-Aventis's global comms director for diabetes, Sarah Sheppard, as an associate director.

The appointment takes the agency to 20 full-time staff. Sheppard will work on Axon's international account for Roche's hepatitis B and C treatment Pegasys. She will lead a five-strong UK-based team, working with five further PROs at Axon's office in Toronto.

Sheppard took up her Paris-based Sanofi-Aventis role when Sanofi and Aventis merged two years ago. An 18-year pharma industry veteran, she was previously with Aventis in Australia.

MD Ralph Sutton said Axon's size had doubled in the past year, on the back of new-business wins from Johnson & Johnson, Novartis and Mundipharma.

Axon has promoted associate director Ruth Slater to director, medical comms and clinical research consulting.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in